Q3 2025 Cellebrite DI Ltd Earnings Call Transcript
Key Points
- Cellebrite DI Ltd (CLBT) reported a 19% growth in Annual Recurring Revenue (ARR) for the 12-month period, reaching $440 million.
- Subscription revenue grew by 21%, driven by strong performance in the US State and Local segment and the Latin America region.
- Adjusted EBITDA exceeded expectations, growing 20% year-on-year with a margin expansion of 60 basis points.
- The company achieved significant progress in converting its digital forensics license base to the Inseyets offering, reaching approximately 47% conversion.
- Cellebrite DI Ltd (CLBT) saw triple-digit ARR growth for its Guardian solution, which is becoming the industry standard for storage and collaboration of sensitive evidential artifacts.
- Cellebrite DI Ltd (CLBT) does not expect a full return to normalized growth in the US Federal segment until calendar 2026.
- The company faces challenges with the timing and magnitude of spending in the US Federal customer segment, impacting growth.
- There are uncertainties related to the completion of the Corellium acquisition, including addressing CFIUS requirements.
- The company experienced a government shutdown, which affected coordination and input across various agencies.
- Cellebrite DI Ltd (CLBT) is cautious about the federal fourth quarter due to normal government seasonality and recent shutdowns.
Welcome to Cellebrite third-quarter 2025 financial results conference call. (Operator Instructions)
I would now like to turn the call over to your first speaker today, Mr. Andrew Kramer. Mr. Kramer, the floor is yours.
Thank you so much, operator. Welcome, everybody, to Cellebrite's third-quarter 2025 financial results call. I'm joined today by Tom Hogan, Cellebrite's CEO; David Barter, Cellebrite's CFO; and Marcus Jewell, our CRO. This call is being recorded, and a replay of recording will be made available on our website shortly after the call along with a copy of our prepared remarks.
Please note a copy of today's press release and financial statements, including GAAP to non-GAAP reconciliations, is available on the Investor Relations website at investors.cellebrite.com. In addition to the press release, we posted a separate investor presentation that provides an overview of our business and our recent financial performance.
I'd like to also remind everybody
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
